Skip to main content
. Author manuscript; available in PMC: 2016 May 23.
Published in final edited form as: Diabetes. 2016 Jan 6;65(4):851–860. doi: 10.2337/db15-1531

Table 1.

List of primary antibodies used in this study.

Primary antibody Manufacturer Dilution
Insulin receptor (InsR) Santa Cruz, sc-711 1/400
Insulin like growth factor receptor type 1 IGF1R Santa Cruz, sc-713 1/400
Catalytic subunits of phosphoinositide 3-kinase (p110α/β) Cell Signalling, 4249, 3011 1/1000
Regulatory subunits of phosphoinositide 3-kinase (p85α) Millipore, 06-195 1/5000 in 1% milk
Kinase Akt Cell Signalling, 9272 1/1000
Phosphorylated (p)Akt Thr308 Cell Signalling, 9275 1/1000
pAkt Ser473 Cell Signalling, 9271 1/1000
Glycogen synthase kinase 3 (GSK3) Cell Signalling, 9315 1/1000
pGSK3 Ser21/9 Cell Signalling, 9331 1/1000
Ribosomal S6 kinase (S6K) Cell Signalling, 2708 1/1000
pS6K Thr 389 Cell Signalling, 9234 1/1000
Eukaryotic translocation initiation factor 4 binding protein (4EBP) Cell Signalling, 9644 1/1000
p4EBP Ser65 Cell Signalling, 9451 1/1000
Mitogen activated protein kinase (MAPK) Cell Signalling, 4695 1/1000
pMAPK Thr202/Tyr204 Cell Signalling, 4370 1/1000
Lipoprotein lipase (LPL) Abcam, 21356 1/1000
Sterol regulatory element binding protein (SREBP) Abcam, 3259 1/200
Fatty acid synthase (FAS) Cell Signalling, 3180 1/1000
Peroxisome proliferator – activated receptor alpha (PPARα) Abcam, 8934 1/1500
Peroxisome proliferator – activated receptor gamma (PPARγ) Santa Cruz, sc-7273 1/200
Fatty acid transport protein 1 (FATP1) Santa Cruz, sc-31955 1/400